178 related articles for article (PubMed ID: 11996173)
21. Standard pleural biopsy versus CT-guided cutting-needle biopsy for diagnosis of malignant disease in pleural effusions: a randomised controlled trial.
Maskell NA; Gleeson FV; Davies RJ
Lancet; 2003 Apr; 361(9366):1326-30. PubMed ID: 12711467
[TBL] [Abstract][Full Text] [Related]
22. [Pathology of primary tumours of the pleura].
Junker K; Krismann M
Zentralbl Chir; 2008 Jun; 133(3):222-6. PubMed ID: 18563685
[TBL] [Abstract][Full Text] [Related]
23. Fine-needle aspiration of malignant mesothelioma with unusual morphologic features: a case report.
Kapur U; Wojcik EM
Diagn Cytopathol; 2007 Mar; 35(3):174-8. PubMed ID: 17415923
[TBL] [Abstract][Full Text] [Related]
24. Early diagnosis of mesothelioma in serous effusions using AgNOR analysis.
Pomjanski N; Motherby H; Buckstegge B; Knops K; Rohn BL; Böcking A
Anal Quant Cytol Histol; 2001 Apr; 23(2):151-60. PubMed ID: 11332082
[TBL] [Abstract][Full Text] [Related]
25. Primary malignant pleural tumors (mesotheliomas) presenting as localized masses. Fine needle aspiration cytologic findings, clinical and radiologic features and review of the literature.
Obers VJ; Leiman G; Girdwood RW; Spiro FI
Acta Cytol; 1988; 32(4):567-75. PubMed ID: 3041723
[TBL] [Abstract][Full Text] [Related]
26. Higher concordance of PD-L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma.
Mansour MSI; Seidal T; Mager U; Dobra K; Brunnström H; Dejmek A
Cancer Cytopathol; 2021 Jun; 129(6):468-478. PubMed ID: 33493383
[TBL] [Abstract][Full Text] [Related]
27. Adenomatoid mesothelioma with intranuclear inclusion bodies: a case report with cytological and histological findings.
Kawai T; Kawashima K; Serizawa H; Miura H; Kyeongil K
Diagn Cytopathol; 2014 May; 42(5):436-40. PubMed ID: 23166110
[TBL] [Abstract][Full Text] [Related]
28. Distinction of mesothelioma from carcinoma in pleural effusions. An immunocytochemical study on routinely processed cytoblock preparations.
Kuhlmann L; Berghäuser KH; Schäffer R
Pathol Res Pract; 1991 May; 187(4):467-71. PubMed ID: 1876528
[TBL] [Abstract][Full Text] [Related]
29. Bronchial cytology in pleural mesothelioma. A report of 3 positive cases, including 1 diagnosed initially on bronchial brushings.
DellaGiustina D; Falconieri G; Bonifacio-Gori D; Zanconati F; DiBonito L; Pizzolitto S
Acta Cytol; 2003; 47(6):1017-22. PubMed ID: 14674071
[TBL] [Abstract][Full Text] [Related]
30. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic efficacy of electron microscopy and pleural effusion cytology for the distinction of pleural mesothelioma and lung adenocarcinoma.
Domínguez-Malagón H; Cano-Valdez AM; González-Carrillo C; Campos-Salgado YE; Lara-Garcia A; Lopez-Mejia M; Corona-Cruz JF; Arrieta O
Ultrastruct Pathol; 2016; 40(5):254-60. PubMed ID: 27405014
[TBL] [Abstract][Full Text] [Related]
32. Management of malignant pleural mesothelioma - part 1: epidemiology, diagnosis, and staging : Consensus of the Austrian Mesothelioma Interest Group (AMIG).
Geltner C; Errhalt P; Baumgartner B; Ambrosch G; Machan B; Eckmayr J; Klikovits T; Hoda MA; Popper H; Klepetko W;
Wien Klin Wochenschr; 2016 Sep; 128(17-18):611-7. PubMed ID: 27619223
[TBL] [Abstract][Full Text] [Related]
33. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
34. [Localized fibrous mesothelioma with bloody pleural effusion; report of a case].
Ogata K; Sakakibara K; Hirano R; Nishiumi N; Tsutsumi M; Ishihara S; Namikawa S
Kyobu Geka; 2004 Feb; 57(2):159-62. PubMed ID: 14978915
[TBL] [Abstract][Full Text] [Related]
35. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
36. Adenocarcinoma simulating mesothelioma.
Corrin B; Dewar A
Ultrastruct Pathol; 1996; 20(4):327-9. PubMed ID: 8837338
[TBL] [Abstract][Full Text] [Related]
37. Malignant mesotheliomas with osseous and cartilaginous differentiation.
Yousem SA; Hochholzer L
Arch Pathol Lab Med; 1987 Jan; 111(1):62-6. PubMed ID: 3099726
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
Mezger J; Lamerz R; Permanetter W
J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of soluble mesothelin-related peptide as a diagnostic marker of malignant pleural mesothelioma effusions: its contribution to cytology.
Canessa PA; Franceschini MC; Ferro P; Battolla E; Dessanti P; Manta C; Sivori M; Pezzi R; Fontana V; Fedeli F; Pistillo MP; Roncella S
Cancer Invest; 2013 Jan; 31(1):43-50. PubMed ID: 23249166
[TBL] [Abstract][Full Text] [Related]
40. [Pleural mesothelioma--case report].
Mestrović IP; Dragicević M; Mosler D; Mestrović T; Mosler EL; Kozmar D; Kranjcević S; Pocanić D; Cavrić G; Skorić KN; Letilović T; Jerkić H; Zeljko H; Kardum-Skelin I
Acta Med Croatica; 2011 Sep; 65 Suppl 1():213-6. PubMed ID: 23126055
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
